Transfluor® assay by iCyte™ imaging cytometer - An advanced cell based screening technology applicable to GPCRs - Kazuo Ozawa Etsuo Shinohara Sachiko Karaki Olympus Co. Genome Medical Business Division January 30, 2004 Norak Biosciences A biotechnology company based in Research Triangle Park, NC, utilizing its Transfluor® technology to become a world leader in the discovery and development of drugs that regulate G protein-coupled receptors (GPCRs). Transfluor® technology A patented, universal GPCR drug discovery technology based on the translocation of arrestin protein from cytosol to GPCR on the membrane.